Prediction of Indolent Prostate Cancer: Validation and Updating of a Prognostic Nomogram

Abstract

Prostate cancers identified in a screening setting have a substantially higher likelihood of being indolent than those predicted by a previously proposed nomogram. However, an updated model can support patients and clinicians when the various treatment options for prostate cancer are considered.